Bemnifosbuvir Sulfate structure

Bemnifosbuvir Sulfate

Candidate
CAS: 2241337-84-6
Sample Stock:

Bemnifosbuvir is an investigational drug under development, primarily investigated for the treatment of hepatitis C virus (HCV) infection. It belongs to the class of NS5B polymerase inhibitors, which work by inhibiting viral replication, thereby aiding in the control and management of the infection.

Related Information

Purity:98%+
Registration:GMP/DMF
View More

Biological Profile

Associated Conditions

kidney disease·COVID-19·chronic hepatitis C virus infection·hepatitis C virus infection

Key Intermediates

5 Items